Send to

Choose Destination
See comment in PubMed Commons below
Gene. 2013 Oct 10;528(2):241-7. doi: 10.1016/j.gene.2013.07.001. Epub 2013 Jul 12.

Mutation spectrum of phenylketonuria in Syrian population: genotype-phenotype correlation.

Author information

  • 1Molecular Biology and Biotechnology Department, Human Genetics Division, Atomic Energy Commission, Damascus, Syria.


Characterization of the molecular basis of phenylketonuria (PKU) in Syria has been accomplished through the analysis of 78 unrelated chromosomes from 39 Syrian patients with PKU. Phenylalanine hydroxylase (PAH) gene mutations have been analyzed by using molecular detection methods based on the restriction fragment length polymorphism (RFLP), artificial constructed restriction sites (ACRS) PCR and direct DNA sequencing. 56.4% of the patients had cPKU. A mutation detection rate of 79.49% was achieved and sixteen different mutations were found: missense 56.25%, splice site 37.5%, and frameshift 6.25%. The predominant mutation in this population sample was p.R261Q G>A, p.F55>Lfs and p.R243Q G>A. No mutation in six PKU patients was observed. In 57.9% of patient genotypes, the metabolic phenotype could be predicted. The identification of the mutations in the PAH gene and the genotype-phenotype correlation should facilitate the evaluation of metabolic phenotypes, diagnosis, implementation of optimal dietary therapy, and determination of prognosis in the patients and genetic counseling for the patient's relatives.


AV; Genotype; HPA; IVS; MHP; PAH; PKU; PRA; Phe; Phenotype; Phenylketonuria; Syria; arbitrary value; hyperphenylalaninemia; intervening sequences; mild hyperphenylalaninemia; phenylalanine; phenylalanine hydroxylase; phenylketonuria; predicted residual activity

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center